Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	4,417	4,411	4,764	3,271	3,071	3,067	2,889	2,914	2,909
Revenue Growth (YoY)	0.14%	-7.41%	45.64%	6.51%	0.14%	6.15%	-0.84%	0.15%	-
Cost of Revenue	1,931	1,913	2,132	1,667	1,470	1,574	1,494	1,409	1,534
Gross Profit	2,486	2,498	2,632	1,604	1,601	1,493	1,395	1,505	1,375
Selling, General & Admin	1,285	1,265	1,403	997	760	735.2	779.8	784.8	916
Research & Development	327	321	369	329	270	246.6	251.7	265.8	291
Other Operating Expenses	1,792	743	1,195	805	414	367.5	596.2	476.3	426.3
Operating Expenses	3,404	2,329	2,967	2,131	1,444	1,349	1,628	1,527	1,633
Operating Income	-918	169	-335	-527	157	143.7	-232.6	-22.4	-257.9
Interest Expense / Income	277	241	236	150	79	29.6	0	0	0
Other Expense / Income	-	-	-	-	-	-	-	-	1.6
Pretax Income	-1,195	-72	-571	-677	78	114.1	-232.6	-22.4	-259.5
Income Tax	36	6	-88	-103	10	27.6	78.1	25.5	-48.7
Net Income	-1,231	-78	-483	-574	68	86.5	-310.7	-47.9	-210.8
Net Income Growth	-	-	-	-	-21.39%	-	-	-	-
Shares Outstanding (Basic)	492	488	487	441	369	314	293	293	-
Shares Outstanding (Diluted)	492	488	487	441	370	314	293	293	-
Shares Change	0.82%	0.23%	10.38%	19.20%	18.04%	6.96%	-	-	-
EPS (Basic)	-2.50	-0.16	-0.99	-1.30	0.18	0.28	-1.06	-0.16	-
EPS (Diluted)	-2.50	-0.16	-0.99	-1.30	0.18	0.28	-1.06	-0.16	-
EPS Growth	-	-	-	-	-35.71%	-	-	-	-
Free Cash Flow	131	281	324	-280	27	360.2	94.3	53	-73.2
Free Cash Flow Per Share	0.27	0.57	0.67	-0.63	0.07	1.15	0.32	0.18	-
Gross Margin	56.28%	56.63%	55.25%	49.04%	52.13%	48.68%	48.29%	51.64%	47.28%
Operating Margin	-20.78%	3.83%	-7.03%	-16.11%	5.11%	4.69%	-8.05%	-0.77%	-8.87%
Profit Margin	-27.87%	-1.77%	-10.14%	-17.55%	2.21%	2.82%	-10.75%	-1.64%	-7.25%
Free Cash Flow Margin	2.97%	6.37%	6.80%	-8.56%	0.88%	11.75%	3.26%	1.82%	-2.52%
Effective Tax Rate	-	-	-	-	12.82%	24.19%	-	-	-
EBITDA	-224	851	381	-10	471	439.7	85.8	232	-22.6
EBITDA Margin	-5.07%	19.29%	8.00%	-0.31%	15.34%	14.34%	2.97%	7.96%	-0.78%
Depreciation & Amortization	694	682	716	517	314	296	318.4	254.4	236.9
EBIT	-918	169	-335	-527	157	143.7	-232.6	-22.4	-259.5
EBIT Margin	-20.78%	3.83%	-7.03%	-16.11%	5.11%	4.69%	-8.05%	-0.77%	-8.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).